143 related articles for article (PubMed ID: 25290415)
1. Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.
Mallick A; Barik S; Ghosh S; Roy S; Sarkar K; Bose A; Baral R
Immunotherapy; 2014; 6(7):821-31. PubMed ID: 25290415
[TBL] [Abstract][Full Text] [Related]
2. Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions.
Goswami S; Bose A; Sarkar K; Roy S; Chakraborty T; Sanyal U; Baral R
Vaccine; 2010 Feb; 28(5):1241-52. PubMed ID: 19969119
[TBL] [Abstract][Full Text] [Related]
3. Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells.
Sarkar M; Ghosh S; Bhuniya A; Ghosh T; Guha I; Barik S; Biswas J; Bose A; Baral R
PLoS One; 2017; 12(4):e0175540. PubMed ID: 28414726
[TBL] [Abstract][Full Text] [Related]
4. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
[TBL] [Abstract][Full Text] [Related]
5. Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.
Barik S; Banerjee S; Mallick A; Goswami KK; Roy S; Bose A; Baral R
PLoS One; 2013; 8(6):e66501. PubMed ID: 23785504
[TBL] [Abstract][Full Text] [Related]
6. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.
Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R
PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300
[TBL] [Abstract][Full Text] [Related]
7. Absence of CD4(+) T cell help generates corrupt CD8(+) effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine.
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Biswas J; Mallick A; Bose A; Baral R
Immunol Lett; 2016 Jul; 175():31-9. PubMed ID: 27178306
[TBL] [Abstract][Full Text] [Related]
8. Neem leaf glycoprotein generates superior tumor specific central memory CD8
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
Vaccine; 2017 Aug; 35(34):4421-4429. PubMed ID: 28684164
[TBL] [Abstract][Full Text] [Related]
9. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
[TBL] [Abstract][Full Text] [Related]
10. Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.
Barik S; Bhuniya A; Banerjee S; Das A; Sarkar M; Paul T; Ghosh T; Ghosh S; Roy S; Pal S; Bose A; Baral R
Int Immunopharmacol; 2013 Sep; 17(1):42-9. PubMed ID: 23747315
[TBL] [Abstract][Full Text] [Related]
11. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
12. Neem leaf glycoprotein suppresses regulatory T cell mediated suppression of monocyte/macrophage functions.
Chakraborty T; Bose A; Goswami KK; Goswami S; Chakraborty K; Baral R
Int Immunopharmacol; 2012 Feb; 12(2):326-33. PubMed ID: 22210373
[TBL] [Abstract][Full Text] [Related]
13. Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
Sarkar K; Goswami S; Roy S; Mallick A; Chakraborty K; Bose A; Baral R
Int Immunopharmacol; 2010 Aug; 10(8):865-74. PubMed ID: 20472099
[TBL] [Abstract][Full Text] [Related]
14. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
[TBL] [Abstract][Full Text] [Related]
15. Neem leaf glycoprotein promotes dual generation of central and effector memory CD8(+) T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity.
Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
Mol Immunol; 2016 Mar; 71():42-53. PubMed ID: 26851529
[TBL] [Abstract][Full Text] [Related]
16. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.
Ganguly N; Das T; Bhuniya A; Guha I; Chakravarti M; Dhar S; Sarkar A; Bera S; Dhar J; Dasgupta S; Saha A; Ghosh T; Das J; Sk UH; Banerjee S; Laskar S; Bose A; Baral R
Cell Commun Signal; 2024 Apr; 22(1):237. PubMed ID: 38649988
[TBL] [Abstract][Full Text] [Related]
17. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.
Mallick A; Ghosh S; Banerjee S; Majumder S; Das A; Mondal B; Barik S; Goswami KK; Pal S; Laskar S; Sarkar K; Bose A; Baral R
Int Immunopharmacol; 2013 Jan; 15(1):73-83. PubMed ID: 23178577
[TBL] [Abstract][Full Text] [Related]
18. Neem leaf glycoprotein directs T-bet-associated type 1 immune commitment.
Bose A; Chakraborty K; Sarkar K; Goswami S; Haque E; Chakraborty T; Ghosh D; Roy S; Laskar S; Baral R
Hum Immunol; 2009 Jan; 70(1):6-15. PubMed ID: 18983881
[TBL] [Abstract][Full Text] [Related]
19. Neem leaf glycoprotein partially rectifies suppressed dendritic cell functions and associated T cell efficacy in patients with stage IIIB cervical cancer.
Roy S; Goswami S; Bose A; Chakraborty K; Pal S; Haldar A; Basu P; Biswas J; Baral R
Clin Vaccine Immunol; 2011 Apr; 18(4):571-9. PubMed ID: 21307275
[TBL] [Abstract][Full Text] [Related]
20. NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8
Bhuniya A; Guha I; Ganguly N; Saha A; Dasgupta S; Nandi P; Das A; Ghosh S; Ghosh T; Haque E; Banerjee S; Bose A; Baral R
Front Oncol; 2020; 10():201. PubMed ID: 32211313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
